{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:36:41Z","timestamp":1792741001490,"version":"4.5.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6]]},"abstract":"<jats:title>ABSTRACT:<\/jats:title>\n          <jats:p>\n                           <jats:italic toggle=\"yes\">Infertility<\/jats:italic>, defined as failure to achieve pregnancy within 12 months of unprotected intercourse or therapeutic donor insemination in women younger than 35 years or within 6 months in women older than 35 years, affects up to 15% of couples. An infertility evaluation may be offered to any patient who by definition has infertility or is at high risk of infertility. Women older than 35 years should receive an expedited evaluation and undergo treatment after 6 months of failed attempts to become pregnant or earlier, if clinically indicated. In women older than 40 years, more immediate evaluation and treatment are warranted. If a woman has a condition known to cause infertility, the obstetrician\u2013gynecologist should offer immediate evaluation. Essential components of an initial workup include a review of the medical history, physical examination, and additional tests as indicated. For the female partner, tests will focus on ovarian reserve, ovulatory function, and structural abnormalities. Imaging of the reproductive organs provides valuable information on conditions that affect fertility. Imaging modalities can detect tubal patency and pelvic pathology and assess ovarian reserve. Male factor is a cause of infertility in 40\u201350% of couples. Given the high prevalence of male factor in infertile heterosexual couples, a basic medical history and evaluation of the male partner are warranted from the outset. A women\u2019s health specialist may reasonably obtain the male partner\u2019s medical history and order the semen analysis. It is also reasonable to refer all male infertility patients to a specialist with expertise in male reproductive medicine. Unexplained infertility may be diagnosed in as many as 30% of infertile couples. At a minimum, these patients should have evidence of ovulation, tubal patency, and a normal semen analysis.<\/jats:p>","DOI":"10.1097\/aog.0000000000003271","type":"journal-article","created":{"date-parts":[[2019,5,25]],"date-time":"2019-05-25T03:07:29Z","timestamp":1558753649000},"page":"e377-e384","source":"Crossref","is-referenced-by-count":239,"title":["Infertility Workup for the Women\u2019s Health Specialist"],"prefix":"10.1097","volume":"133","member":"276","reference":[{"key":"R1-20230711","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.fertnstert.2012.09.023","article-title":"Definitions of infertility and recurrent pregnancy loss: a committee opinion","volume":"99","year":"2013","journal-title":"Fertil Steril"},{"key":"R3-20230711","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.fertnstert.2015.03.019","article-title":"Diagnostic evaluation of the infertile female: a committee opinion. Practice Committee of the American Society for Reproductive Medicine","volume":"103","year":"2015","journal-title":"Fertil Steril"},{"key":"R4-20230711","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/01.AOG.0000444440.96486.61","article-title":"Female age-related fertility decline. Committee Opinion No. 589. American College of Obstetricians and Gynecologists","volume":"123","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R5-20230711","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1097\/AOG.0000000000002765","article-title":"Marriage and family building equality for lesbian, gay, bisexual, transgender, queer, intersex, asexual, and gender nonconforming individuals. ACOG Committee Opinion No. 749. American College of Obstetricians and Gynecologists","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R6-20230711","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.fertnstert.2013.08.042","article-title":"Access to fertility treatment by gays, lesbians, and unmarried persons: a committee opinion. Ethics Committee of American Society for Reproductive Medicine","volume":"100","year":"2013","journal-title":"Fertil Steril"},{"key":"R7-20230711","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1097\/AOG.0000000000003013","article-title":"Prepregnancy counseling. ACOG Committee Opinion No. 762. American College of Obstetricians and Gynecologists","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"key":"R8-20230711","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.fertnstert.2014.12.093","article-title":"Testing and interpreting measures of ovarian reserve: a committee opinion. Practice Committee of the American Society for Reproductive Medicine","volume":"103","year":"2015","journal-title":"Fertil Steril"},{"key":"R9-20230711","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/humupd\/dml034","article-title":"A systematic review of tests predicting ovarian reserve and IVF outcome","volume":"12","author":"Broekmans","year":"2006","journal-title":"Hum Reprod Update"},{"key":"R10-20230711","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1093\/humrep\/del291","article-title":"Serum anti-Mullerian hormone throughout the human menstrual cycle","volume":"21","author":"La Marca","year":"2006","journal-title":"Hum Reprod"},{"key":"R11-20230711","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s10815-018-1141-5","article-title":"Multi-center clinical evaluation of the Access AMH assay to determine AMH levels in reproductive age women during normal menstrual cycles","volume":"35","author":"Gracia","year":"2018","journal-title":"J Assist Reprod Genet"},{"key":"R12-20230711","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.fertnstert.2007.12.013","article-title":"The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count","volume":"91","author":"Broer","year":"2009","journal-title":"Fertil Steril"},{"key":"R13-20230711","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.fertnstert.2007.03.100","article-title":"The predictive value for in vitro fertility delivery rates is greatly impacted by the method used to select the threshold between normal and elevated basal follicle-stimulating hormone","volume":"89","author":"Scott","year":"2008","journal-title":"Fertil Steril"},{"key":"R14-20230711","first-page":"275","article-title":"The use of antim\u00fcllerian hormone in women not seeking fertility care. Committee Opinion No. 773. American College of Obstetricians and Gynecologists","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"key":"R15-20230711","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1097\/AOG.0000000000001952","article-title":"Carrier screening for genetic conditions. Committee Opinion No. 691. American College of Obstetricians and Gynecologists","volume":"129","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R16-20230711","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/humrep\/der092","article-title":"ESHRE consensus on the definition of \u201cpoor response\u201d to ovarian stimulation for in vitro fertilization: the Bologna criteria. ESHRE working group on Poor Ovarian Response Definition","volume":"26","author":"Ferraretti","year":"2011","journal-title":"Hum Reprod"},{"key":"R17-20230711","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.rbmo.2016.07.010","article-title":"Ovarian function during hormonal contraception assessed by endocrine and sonographic markers: a systematic review","volume":"33","author":"D'Arpe","year":"2016","journal-title":"Reprod Biomed Online"},{"key":"R18-20230711","first-page":"308","article-title":"Evaluation and treatment of infertility [published erratum appears in Am Fam Physician 2015;92:437]","volume":"91","author":"Lindsay","year":"2015","journal-title":"Am Fam Physician"},{"key":"R19-20230711","doi-asserted-by":"crossref","first-page":"e0134473","DOI":"10.1371\/journal.pone.0134473","article-title":"Ovulation prevalence in women with spontaneous normal-length menstrual cycles\u2014a population-based cohort from HUNT3, Norway","volume":"10","author":"Prior","year":"2015","journal-title":"PLoS One"},{"key":"R20-20230711","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/bmj.288.6410.7","article-title":"Interpretation of single progesterone measurement in diagnosis of anovulation and defective luteal phase: observations on analysis of the normal range","volume":"288","author":"Wathen","year":"1984","journal-title":"Br Med J (Clin Res Ed)"},{"key":"R21-20230711","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1172\/JCI111370","article-title":"Neuroendocrine regulation of the corpus luteum in the human. Evidence for pulsatile progesterone secretion","volume":"73","author":"Filicori","year":"1984","journal-title":"J Clin Invest"},{"key":"R22-20230711","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1097\/AOG.0000000000002656","article-title":"Polycystic ovary syndrome. ACOG Practice Bulletin No. 194. American College of Obstetricians and Gynecologists","volume":"131","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R23-20230711","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group","volume":"97","author":"Fauser","year":"2012","journal-title":"Fertil Steril"},{"key":"R25-20230711","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"R26-20230711","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. Androgen Excess Society","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R27-20230711","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/humupd\/dml036","article-title":"A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome","volume":"12","author":"Boomsma","year":"2006","journal-title":"Hum Reprod Update"},{"key":"R28-20230711","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/humrep\/del521","article-title":"The predictive s value of medical history taking and Chlamydia IgG ELISA antibody testing (CAT) in the selection of subfertile women for diagnostic laparoscopy: a clinical prediction model approach","volume":"22","author":"Coppus","year":"2007","journal-title":"Hum Reprod"},{"key":"R29-20230711","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/AOG.0000000000001588","article-title":"Technology Assessment No. 12. American College of Obstetricians and Gynecologists","volume":"128","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R30-20230711","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.jmig.2014.05.017","article-title":"Contrast ultrasonography for tubal patency","volume":"21","author":"Luciano","year":"2014","journal-title":"J Minim Invasive Gynecol"},{"key":"R31-20230711","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/humrep\/deu024","article-title":"Hysterosalpingosonography for diagnosing tubal occlusion in subfertile women: a systematic review with meta-analysis","volume":"29","author":"Maheux-Lacroix","year":"2014","journal-title":"Hum Reprod"},{"key":"R32-20230711","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.fertnstert.2017.06.034","article-title":"Removal of myomas in asymptomatic patients to improve fertility and\/or reduce miscarriage rate: a guideline. Practice Committee of the American Society for Reproductive Medicine","volume":"108","year":"2017","journal-title":"Fertil Steril"},{"key":"R33-20230711","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.fertnstert.2006.05.044","article-title":"A prospective evaluation of uterine abnormalities by saline infusion sonohysterography in 1,009 women with infertility or abnormal uterine bleeding","volume":"86","author":"Tur-Kaspa","year":"2006","journal-title":"Fertil Steril"},{"key":"R34-20230711","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/uog.17352","article-title":"Accuracy of saline contrast sonohysterography in detection of endometrial polyps and submucosal leiomyomas in women of reproductive age with abnormal uterine bleeding: systematic review and meta-analysis","volume":"50","author":"Bittencourt","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R35-20230711","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/uog.14825","article-title":"Accuracy of three-dimensional ultrasound compared with magnetic resonance imaging in diagnosis of Mullerian duct anomalies using ESHRE-ESGE consensus on the classification of congenital anomalies of the female genital tract","volume":"46","author":"Graupera","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R36-20230711","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0015-0282(99)00532-4","article-title":"Diagnostic accuracy of sonohysterography, transvaginal sonography, and hysterosalpingography in patients with uterine cavity diseases","volume":"73","author":"Soares","year":"2000","journal-title":"Fertil Steril"},{"key":"R37-20230711","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0168-8278(98)80003-2","article-title":"Role of breast-feeding in transmission of hepatitis C virus to infants of HCV-infected mothers","volume":"29","author":"Kumar","year":"1998","journal-title":"J Hepatol"},{"key":"R38-20230711","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/j.fertnstert.2014.12.103","article-title":"Diagnostic evaluation of the infertile male: a committee opinion. Practice Committee of the American Society for Reproductive Medicine","volume":"103","year":"2015","journal-title":"Fertil Steril"},{"issue":"suppl 1","key":"R39-20230711","first-page":"S111","article-title":"Effectiveness and treatment for unexplained infertility. Practice Committee of the American Society for Reproductive Medicine","volume":"86","year":"2006","journal-title":"Fertil Steril"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006250-201906000-00047","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T19:25:40Z","timestamp":1689103540000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201906000-00047"}},"subtitle":["ACOG Committee Opinion, Number 781"],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000003271","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]}}}